Ketamine Test Card; LumiQuick,. Santa Clara, CA 95054
FDA Device Recall #Z-1393-2014 — Class II — March 4, 2014
Recall Summary
| Recall Number | Z-1393-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 4, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | LumiQuick Diagnostics Inc. |
| Location | Santa Clara, CA |
| Product Type | Devices |
| Quantity | ALL |
Product Description
Ketamine Test Card; LumiQuick,. Santa Clara, CA 95054
Reason for Recall
Products shipped to US locations that do not have approved applications for PMA , IDE or 510(k) clearance.
Distribution Pattern
Distributed in the states of CA, FL, NJ, TX, and NY.
Lot / Code Information
Catalog number: 74040 All lots
Other Recalls from LumiQuick Diagnostics Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1345-2014 | Class II | Adenovirus Antigen Test Card; LumiQuick, Sa... | Mar 4, 2014 |
| Z-1372-2014 | Class II | Benzodiazepine Strip; LumiQuick. Santa Clar... | Mar 4, 2014 |
| Z-1363-2014 | Class II | Fecal Occult Blood Test Strip; LumiQuick. S... | Mar 4, 2014 |
| Z-1375-2014 | Class II | Cocaine Test Card; LumiQuick. Santa Clara, ... | Mar 4, 2014 |
| Z-1386-2014 | Class II | Morphine Strips (2000); LumiQuick, Santa Cl... | Mar 4, 2014 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.